A nearly decade-long patent infringement clash between two pharmaceutical heavyweights reached its apogee on March 27, 2023, when the Supreme Court heard the two parties (and the.
The Supreme Court's decision to grant certiorari in Amgen v. Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure.
The Supreme Court's decision to grant certiorari in Amgen v. Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure.